Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma
Clinical trial NCT00821080 · COMPLETED
Trial details
- NCT number
- NCT00821080
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2015-02-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.